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Abstract
Reported associations between vitamin  K1 and both all-cause and cause-specific mortality are conflicting. The 56,048 
participants from the Danish Diet, Cancer, and Health prospective cohort study, with a median [IQR] age of 56 [52–60] 
years at entry and of whom 47.6% male, were followed for 23 years, with 14,083 reported deaths. Of these, 5015 deaths 
were CVD-related, and 6342 deaths were cancer-related. Intake of vitamin  K1 (phylloquinone) was estimated from a food-
frequency questionnaire (FFQ), and its relationship with mortality outcomes was investigated using Cox proportional hazards 
models. A moderate to high (87–192 µg/d) intake of vitamin  K1 was associated with a lower risk of all-cause [HR (95%CI) 
for quintile 5 vs quintile 1: 0.76 (0.72, 0.79)], cardiovascular disease (CVD)-related [quintile 5 vs quintile 1: 0.72 (0.66, 
0.79)], and cancer-related mortality [quintile 5 vs quintile 1: 0.80 (0.75, 0.86)], after adjusting for demographic and lifestyle 
confounders. The association between vitamin  K1 intake and cardiovascular disease-related mortality was present in all 
subpopulations (categorised according to sex, smoking status, diabetes status, and hypertension status), while the association 
with cancer-related mortality was only present in current/former smokers (p for interaction = 0.002). These findings suggest 
that promoting adequate intakes of foods rich in vitamin  K1 may help to reduce all-cause, CVD-related, and cancer-related 
mortality at the population level.
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Introduction
Vitamin K, a group of fat-soluble vitamins, is important 
for blood clotting, as well as bone and vascular health 
and other physiological functions [1]. In the body vitamin 
K act as an essential cofactor for the γ-carboxylation of 
glutamate residues on vitamin K-dependant proteins [1]. 
There are two main forms of dietary vitamin K: vitamin 
 K1 (phylloquinone) and vitamin  K2 (menaquinones; MKs). 
Vitamin  K1 is most abundant in green leafy vegetables 
and their oils, but is also present in smaller concentra-
tions in the majority of food groups including fruit, meat 
and dairy products [2]. Studies on vitamin K absorption 
are lacking, but from the limited data available, the bio-
availability of vitamin  K1 from vegetables appears to be 
low (5–10%), with higher absorption observed from oil-
based sources [3]. Vitamin  K2 is a complex group of com-
pounds differing from one another by the length of their 
side chain, which ranges from four to thirteen isoprenoid 
unit repeats (MK-4 to MK-13). MK-4 is found in animal 
products, such as meat and eggs, while all other MKs are 
typically found in fermented foods [3]. There is currently 
limited information available on the metabolism, absorp-
tion, bioavailability, and dietary sources of the different 
vitamin  K2 isomers [4]. In addition, few food composition 
databases of vitamin K include all isoforms of vitamin  K2, 
if they include vitamin  K2 at all. As such, it is not currently 
possible to accurately estimate dietary intakes of vitamin 
 K2, making it difficult to draw conclusions regarding its 
association with health outcomes in observational studies.
The effects of vitamin K on coagulation are well-estab-
lished, and vitamin K is now recognized to be required for 
the prevention of osteoporotic bone loss and vascular cal-
cification, implicated in the development of cardiovascular 
diseases [5]. There are numerous mechanisms by which 
vitamin K may moderate cardiovascular health; key path-
ways include the activation of the vitamin K-dependant 
protein, Matrix Gla Protein, a potent inhibitor of arterial 
calcification [6], and the reduction of systematic inflam-
mation [7, 8]. Vitamin  K1 is hypothesised to have anti-
cancer effects and has been found to inhibit some human 
tumour cell lines, but the evidence is weak [9, 10]. Evi-
dence from observational studies is limited and provides 
conflicting reports as to the association between vitamin 
 K1 and both all-cause [11–14] and cause-specific mortal-
ity, including CVD- [11, 13, 14] and cancer-related mor-
tality [11, 13, 15, 16]. The inconsistent findings between 
observational studies warrants further investigation of the 
potential associations in a large cohort setting.
Our primary aim was to investigate whether dietary 
intakes of vitamin  K1 were associated with all-cause, 
CVD-related, or cancer-related mortality in the Danish 
Diet, Cancer, and Health cohort. Our secondary aim was 
to identify subpopulations that may benefit the most from 
higher vitamin  K1 intakes.
Methods
Study population
The Danish Diet, Cancer, and Health cohort study recruited 
57,053 participants from December 1993 to May 1997 who 
were between the ages of 50–65 years and who resided in 
the greater area of Copenhagen and Aarhus, Denmark. Of 
these, 56,468 were without cancer and completed a food 
frequency questionnaire (FFQ) at enrolment. Details of the 
study design, measurement procedures and participant char-
acteristics for the Danish Diet, Cancer, and Health study 
have been previously published [17]. Crosslinking between 
the Danish Diet, Cancer, and Health cohort and nationwide 
registers was enabled by the unique and permanent civil 
registration numbers provided to all Danish residents. Five 
databases were linked to the cohort on the individual level: 
(1) The Civil Registration System which includes data on 
age, sex and vital status; (2) The Integrated Database for 
Labour Market Research [18] which provides information 
on annual income and employment status; (3) The Danish 
Register of Causes of Death contains information on the 
cause of death since 1994 by International Classification of 
Diseases (ICD) codes; (4) The Danish National Prescrip-
tion Registry containing information on all filled prescrip-
tions since 1994; (5) The Danish National Patient Register 
(DNPR) provides data on all hospital admissions in Den-
mark since 1978 with all diagnoses defined by ICD codes. 
The 8th revision of the ICD (ICD-8) was used until 1993 
and the  10th revision (ICD-10) from 1994 onwards. Partici-
pants were excluded from analyses in the present study if 
their data was missing or implausible (n = 215), or if they 
had extreme energy intakes [< 2,092 kJ/day (< 500 kcal/day) 
and > 20,920 kJ/day (> 5000 kcal/day)] (n = 205). This left 
56,048 participants for analysis in the present study (Sup-
plementary Fig. 1). This study was approved by the Danish 
Data Protection Agency (Ref no 2012–58-0004 I-Suite nr: 
6357, VD-2018–117).
Exposures
The exposures of interest in this study were intakes of vita-
min  K1 estimated from a 192-item semi-quantitative, self-
administered FFQ, mailed to participants prior to their visit 
to one of two study centres. The FFQ has been validated for 
macro- and micro-nutrients against two times seven days of 
weighed diet records [19]. The FFQ asked participants to 
indicate their usual frequency of intake of different food and 
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beverage items over the previous 12 months, using a 12-cat-
egory frequency scale that ranged from never to eight times 
or more per day [17]. The intake of dietary vitamin  K1 was 
estimated by multiplying the food/beverage item consumed 
(g/d) by the mean vitamin  K1 value (μg/g) obtained from 
the Frida Food Data database [20] and, when a value was 
not available, the United States Department of Agriculture 
(USDA) database [21], as described previously [22].
Study outcomes
The National Death Register was used to obtain the cause of 
death, while the date of death and vital status were obtained 
from the Civil Registration System for each participant. 
Cardiovascular disease-related mortality was defined as any 
ICD-10 diagnosis registered as a cause of death related to 
CVD (I00-I99) and cancer-related mortality was defined as 
any ICD-10 diagnosis registered as a cause of death related 
to cancer (C00-C99), dated after participant enrolment (Sup-
plementary Table 1).
Covariates
Self-administered questionnaires were used to obtain infor-
mation on sex, age, education, smoking habits, alcohol con-
sumption, and physical activity [23] upon enrolment into 
the study. Anthropometric and clinical measurements, such 
as BMI or total blood cholesterol, were taken at the study 
centres. Annual income, used as a proxy for socio-economic 
status, was defined as household income after taxation and 
interest for the value of the Danish currency in 2015. Income 
was estimated as the mean income over 5 years, up to and 
including the year of study inclusion, divided into quartiles. 
ICD-8 and ICD-10 codes (Supplementary Table 1) were 
used to determine the presence of prevalent chronic kid-
ney disease (CKD), chronic obstructive pulmonary disease 
(COPD), ischemic heart disease (IHD), peripheral artery dis-
ease (PAD), ischemic stroke, heart failure, atrial fibrillation, 
and cancer at baseline. Prevalent CVD was defined by the 
presence of at least one diagnosis of IHD, PAD, ischemic 
stroke, heart failure, or atrial fibrillation prior to recruit-
ment. For diabetes mellitus, only self-reported data were 
used due to the low validity of ICD-codes in the  DNPR27. 
The use of antihypertensive medications or statin therapy 
at study enrolment were determined from the combination 
of Anatomical Therapeutic Chemical (ATC) codes in the 
Danish National Prescription Registry and self-reported use. 
Presence of hypercholesterolemia was defined using self-
reported data. The presence of hypertension at baseline was 
determined through self-reported data or if ≥ 2 prescriptions 
of antihypertensive medication (ATC codes described in 
Supplementary Table 2) were claimed within 180 days prior 
to study enrolment [24]. The use of vitamin K antagonists 
(VKA) prior to baseline were also determined through ATC 
codes (ATC code: B01AA).
Statistical analysis
Participants were followed for a maximum of 23 years, from 
the date of enrolment until the date of death, emigration, or 
end of follow-up (August, 2017), whichever was the first 
occurrence. Correlations between vitamin  K1 intake and veg-
etable intake were examined using Spearman’s correlation 
coefficients. Vitamin  K1 intake was categorized into quin-
tiles of intake (i.e. 20% of participants from the total study 
population in each category) for the purpose of presentation, 
but not for modelling. Potential nonlinear relationships were 
examined using restricted cubic splines, with hazard ratios 
(HRs) obtained from Cox proportional hazards models, 
using the ‘rms’ R package with the rcs() function [25]. HRs 
with 95% confidence intervals (CIs) were plotted for each 
unit of vitamin  K1 intake (continuous), with the median vita-
min  K1 intake in quintile 1 as the reference level. For visual 
simplicity, the x-axes of all cubic splines were restricted to 
be within three standard deviations of the mean. The test of 
nonlinearity used a chi-squared test to compare the model 
with only the linear term to the model that included the cubic 
spline terms. Cox proportional hazards assumptions were 
tested using log–log plots of the survival function vs. time 
which were assessed for parallel appearance, with no vio-
lations found. Four models of adjustment were used: (1a) 
minimally adjusted; (1b) multivariable-adjusted; (2) mul-
tivariable-adjusted including potential dietary confounders 
that are not also a major dietary source of the exposure; 
(3) exploratory model including covariates in model 2 plus 
major dietary sources of the exposure (information of spe-
cific covariates used is presented in the relevant table and 
figure legends as well as in Supplementary Table 3). Covari-
ates were chosen a priori using knowledge of potential con-
founders of vitamin  K1 intake and either CVD- or cancer-
related mortality. In a sensitivity analysis, participants were 
excluded if they were prescribed VKA at baseline (n = 319) 
and censored if they were prescribed a VKA during follow-
up (n = 6690). To investigate potential effect modification, 
analyses were stratified by subgroups with differing risk of 
CVD and/or cancer, namely, sex, baseline smoking status 
(ever versus never smokers), diabetes status, and presence of 
hypertension. We tested for interactions using a chi-squared 
test comparing nested models. To identify subpopulations 
that may benefit the most from higher vitamin  K1 intakes, 
standard logistic regression models were used to obtain the 
20-year absolute risk estimates of mortality. For these analy-
ses, a binary outcome indicating death during 20 years of 
follow-up was used. Unless indicated by the stratification 
variable, these estimates are for an ‘average’ non-smoking 
cohort participant, aged 56 years, with a BMI of 25.5 kg/
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m2, a total daily metabolic equivalent score of 56, with a 
mean household income of 394,701–570,930 DKK/year, 
8–10 years of education, an alcohol intake of 13 g/day, and 
no prevalent chronic disease at baseline (diabetes, cancer, 
chronic obstructive pulmonary disease, or chronic kidney 
disease). To investigate whether associations between vita-
min  K1 and mortality outcomes were evident amongst par-
ticipants with different levels of vegetable consumption, we 
stratified our primary analysis by tertiles of total vegetable 
intake.
Analyses were undertaken using STATA/IC (14.2 Stata-
Corp LLC) and R statistics (R Core Team, 2019) [26].
Results
Baseline characteristics
The cohort, comprised of 56,048 Danish residents, had a 
median [IQR] age of 56 [52–60] years at entry and were fol-
lowed up for 21 [20–22] years. During the 1,085,186 person-
years of follow-up, 14,083 participants died from any cause. 
Of these, 5015 deaths were CVD-related, and 6342 deaths 
were cancer-related. The baseline characteristics of the study 
population, overall and stratified by vitamin  K1 and vitamin 
 K2 intake quintiles are shown in Table 1.
At baseline, the median intake [IQR] of vitamin  K1 was 
113.3 µg/day [80.2–150.6]. There was a strong correla-
tion between vitamin  K1 and vegetable intake (Spearman’s 
rho = 0.82, p < 0.001). Compared to participants in the low-
est quintile of vitamin  K1 intake, a greater percentage of par-
ticipants in the highest quintile were male, more physically 
active, had a higher level of education, had a higher income, 
had never smoked, and had a higher energy intake and a 
higher intake of alcohol, fish, red meat, wholegrains, fruits 
and vegetables. Furthermore, they had a higher prevalence 
of diabetes, but a lower prevalence of hypertension, COPD, 
IHD, PAD, stroke, and heart failure.
Associations between vitamin  K1 intake 
and all‑cause mortality
The association between vitamin  K1 intake and all-cause 
mortality was non-linear (p for non-linearity < 0.001); the 
gradient of the inverse association started to decrease at 
intakes above approximately 100 µg/day (Fig. 1). The HRs 
for all-cause and cause-specific mortality, by quintiles of 
vitamin  K1 intake, are shown in Table 2. Participants with 
the highest intakes of vitamin  K1 (quintile 5), had the low-
est risk of all-cause mortality relative to participants in 
quintile 1 [HR: 0.78 (0.74, 0.81); Model 1b]. There was a 
clear relationship between vitamin  K1 intake and all-cause 
mortality after adjusting for potential dietary confounders 
(Model 2). 
Associations between vitamin  K1 intake 
and CVD‑related mortality
The association between vitamin  K1 intake and CVD-related 
mortality was non-linear (p for non-linearity < 0.001; Fig. 1). 
Relative to participants in quintile 1 and after adjusting for 
demographic and lifestyle confounders, participants in quin-
tile 5 had the lowest risk of CVD-related mortality [HR: 0.74 
(0.68, 0.81); Model 1b; Table 2]. A clear inverse association 
remained after further adjustments for dietary confounders 
(Models 2 and 3; Table 2).
Associations between vitamin  K1 intake 
and cancer‑related mortality
The association between vitamin  K1 intake and cancer-
related mortality was non-linear (p for non-linearity < 0.01; 
Fig. 1). Relative to participants in quintile 1 and after adjust-
ing for demographic and lifestyle confounders, participants 
in quintile 5 had the lowest risk of cancer-related mortality 
[HR: 0.82 (0.77, 0.88); Model 1b; Table 2]. A clear inverse 
relationship remained after adjusting for potential dietary 
confounders (Model 2) and vitamin  K1 intake (Model 3), 
although the point estimates levelled beyond moderate 
intakes (quintile 3).
Sensitivity analysis
The exclusion of participants prescribed a VKA (n = 7,009) 
did not change the relationship of vitamin  K1 intake with 
mortality outcomes (Supplementary Fig. 2).
Stratified analysis
The association between vitamin  K1 intake and CVD-related 
mortality was present in all subgroups investigated (p for 
interaction > 0.05 for all; Fig. 2). However, as the incidence 
of CVD-mortality was higher in smokers, and those with 
diabetes, the absolute difference (vitamin  K1 intake quintile 
5 – vitamin  K1 intake quintile 1) in the 20-year estimated 
risk of CVD-mortality was greater in these subgroups [cur-
rent smokers (2.53% for males, 1.43% for females); persons 
with diabetes (2.46% for males, 1.39% for females); Sup-
plementary Table 4].
The association between vitamin  K1 intake and cancer-
related mortality was only present in current/former smok-
ers (p for interaction = 0.002; Fig. 3). As cancer-mortality 
incidence was higher in current smokers, the absolute dif-
ference (vitamin  K1 intake quintile 5 – vitamin  K1 intake 
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Table 1  Baseline characteristics of study population by vitamin  K1 intake quintiles
Total population Vitamin  K1 intake quintiles
n = 56,048 Q1 n = 11,210 Q2 n = 11,209 Q3 n = 11,210 Q4 n = 11,209 Q5 n = 11,210
Demographics
Total vitamin  K1 intake (µg/d) 113 [80–151] 57 [47–66] 87 [80–94] 113 [107–120] 142 [134–151] 192 [174–219]
Sex (male) 26,666 (47.6) 4876 (43.5) 5119 (46.5) 5210 (46.5) 5495 (49.0) 5966 (53.2)
Age (years) 56 [52–60] 56 [53–60] 56 [52–60] 56 [52–60] 56 [52–60] 56 [52–60]
BMI (kg/m2) 26 [9, 23–27] 26 [9, 10, 24–27] 26 [9, 24–27] 26 [9, 23–27] 25 [9, 23–27] 25 [9, 23–27]
MET score 57 [37–85] 49 [31–76] 54 [35–82] 57 [38–84] 59 [40–86] 64 [42–93]
Smoking status
 Never 19,666 (35.1) 3241 (28.9) 3798 (33.9) 4183 (37.3) 4299 (38.4) 4145 (37.0)
 Former 16,153 (28.8) 2,703 (24.1) 3,145 (28.1) 3,226 (28.8) 3,427 (30.6) 3,652 (32.6)
 Current 20,229 (36.1) 5266 (47.0) 4266 (38.1) 3801 (33.9) 3483 (31.1) 3413 (30.4)
Smoking pack-years 9 [0–26] 19 [0–32] 12 [0–28] 8 [0–25] 7 [0–23] 5 [0–21]
Education
  ≤ 7 years 18,466 (32.9) 4818 (43.0) 4146 (37.0) 3673 (32.8) 3193 (28.5) 2636 (23.5)
 8–10 years 25,817 (46.1) 5038 (44.9) 5271 (47.0) 5336 (47.6) 5205 (46.4) 4967 (44.3)
  ≥ 11 years 11,737 (20.9) 1345 (12.0) 1790 (16.0) 2199 (19.6) 2804 (25.0) 3599 (32.1)
Annual income
  ≤ 394,700 DKK/year 13,919 (24.8) 3680 (32.8) 2829 (25.2) 2580 (23.0) 2395 (21.4) 2435 (21.7)
 394,701–570,930 DKK/year 14,018 (25.0) 3097 (27.6) 2979 (26.6) 2895 (25.8) 2545 (22.7) 2502 (22.3)
 570,931–758,297 DKK/year 14,054 (25.1) 2584 (23.1) 2921 (26.1) 2966 (26.5) 2964 (26.4) 2619 (23.4)
  > 758,297 DKK/year 14,057 (25.1) 1849 (16.5) 2480 (22.1) 2769 (24.7) 3305 (29.5) 3654 (32.6)
Hypertensive 9428 (16.8) 2027 (18.1) 1916 (17.1) 1910 (17.0) 1833 (16.4) 1742 (15.5)
Hypercholesterolemic 4,193 (7.5) 846 (7.5) 830 (7.4) 885 (7.9) 839 (7.5) 793 (7.1)
Comorbidities
Diabetes 1182 (2.1) 197 (1.8) 188 (1.7) 205 (1.8) 229 (2.0) 363 (3.2)
COPD 858 (1.5) 230 (2.1) 180 (1.6) 141 (1.3) 163 (1.5) 144 (1.3)
CKD 204 (0.4) 29 (0.3) 55 (0.5) 46 (0.4) 40 (0.4) 34 (0.3)
Cancer 247 (0.4) 66 (0.6) 44 (0.4) 49 (0.4) 43 (0.4) 45 (0.4)
Heart failure 220 (0.4) 63 (0.6) 43 (0.4) 28 (0.2) 48 (0.4) 38 (0.3)
Atrial fibrillation 451 (0.8) 95 (0.8) 83 (0.7) 86 (0.8) 86 (0.8) 101 (0.9)
IHD 2,200 (3.9) 524 (4.7) 465 (4.1) 396 (3.5) 400 (3.6) 415 (3.7)
PAD 498 (0.9) 145 (1.3) 124 (1.1) 85 (0.8) 82 (0.7) 62 (0.6)
Stroke 787 (1.4) 201 (1.8) 177 (1.6) 132 (1.2) 142 (1.3) 135 (1.2)
Medication use
Insulin treated 695 (1.2) 103 (0.9) 105 (0.9) 111 (1.0) 132 (1.2) 244 (2.2)
Antihypertensive 6904 (12.7) 1482 (13.2) 1413 (12.6) 1392 (12.4) 1350 (12.0) 1267 (11.3)
Statin 1101 (2.0) 221 (2.0) 238 (2.1) 225 (2.0) 208 (1.9) 209 (1.9)
HRT (% of females)
 Never 15,972 (54.4) 3214 (20.1) 3064 (19.2) 3324 (20.8) 3232 (20.2) 3138 (19.6)
 Current 8825 (30.0) 1736 (19.7) 1781 (20.2) 1771 (20.1) 1730 (19.6) 1807 (20.5)
 Former 4553 (15.5) 1010 (22.2) 841 (20.3) 841 (18.5) 885 (19.4) 895 (19.7)
NSAID 18,161 (32.6) 3656 (32.9) 3689 (33.1) 3621 (32.5) 3647 (32.7) 3548 (31.8)














 Total fish intake (g/d) 38 [25–55] 28 [18–41] 34 [23–49] 38 [27–54] 43 [30–60] 50 [34–70]
 Red meat intake (g/d) 78 [57–107] 67 [49–90] 76 [56–102] 81 [59–108] 83 [61- 113] 87 [61–121]
 Processed meat intake (g/d) 25 [14–40] 23 [13–36] 25 [15–39] 25 [15–40] 25 [15–42] 26 [14–43]
 Fruit intake (g/d) 171 [94–281] 109 [50–188] 148 [82–238] 175 [103–277] 200 [123–313] 241 [146–381]
 Vegetable intake (g/d) 161 [104–231] 77 [53–108] 128 [94–166] 167 [127–211] 203 [158–256] 270 [206–345]
 Wholegrain intake (g/d) 128 [86–175] 88 [65–125] 117 [81–164] 129 [92–171] 153 [110–194] 172 [123–224]
 Alcohol intake (g/d) 13 [6–29] 12 [4–30] 12 [6–29] 13 [6–28] 14 [7–29] 14 [7–29]
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quintile 1) in the 20-year estimated risk of cancer-mor-
tality was the largest in this subgroup [current smokers 
(3.51% males, 2.96% females); Supplementary Table 5].
To investigate whether vitamin  K1 is just a marker 
of higher vegetable intake, due to the high correlation 
between vitamin  K1 intake and vegetable intake, we 1) 
adjusted for total vegetable intake in Model 3, and 2) we 
stratified our primary analysis by tertiles of total vegeta-
ble intake. Adjusting for total vegetable intake did not 
materially alter the observed associations (Table 2). Fur-
thermore, there was evidence of an inverse association 
between vitamin  K1 intakes and all-cause mortality in all 
tertiles of total vegetable intake (Model 1b; Supplemen-
tary Table 6).
Discussion
In this large prospective cohort study of 56,048 Danish 
men and women, a moderate to high intake of vitamin  K1 
was associated with a lower risk of all-cause mortality, 
CVD-related mortality, and cancer-related mortality, after 
adjusting for potential lifestyle confounders. On a relative 
scale, the association between vitamin  K1 and CVD-related 
mortality was not modified by sex or smoking, diabetes and 
hypertension status. However, as CVD-mortality incidence 
was higher in smokers, and those with diabetes, the absolute 
difference in the 20-year estimated risk of CVD-mortality 
was greater in these subgroups. The association between 
vitamin  K1 intakes and cancer-mortality was only present 
in current and former smokers.
To our knowledge, four epidemiological studies have 
investigated the associations between vitamin  K1 intake 
and all-cause mortality, two of which reported no associa-
tion [11, 12]. Notably, Zwakenberg et al. reported relatively 
high vitamin  K1 intakes in the EPIC-Netherlands cohort 
[11] which may explain the lack of an association; the mean 
intake in the lowest energy-adjusted quartile was estimated 
to be 87.7 ± 17.5 µg/d which is higher than the recommended 
adequate intake of 70 µg/d of vitamin  K1 set by the Euro-
pean Food Safety Authority [4]. In the present study, we 
saw a threshold at approximately 100 µg/d of vitamin  K1 
(equivalent to approximately 1 cup of leafy green vegeta-
bles), after which there appeared to be minimal additional 
benefit. As such, participants of the EPIC-NL cohort in the 
lowest intake quartile may be a poor reference to observe 
inverse associations due to their diet likely containing ade-
quate vitamin  K1. Similarly, the study by Geleijnse et al. also 
had a high vitamin  K1 intake in their reference group, with a 
median energy-adjusted lower tertile of 154.6 µg/d [12]. The 
other two studies reported a significant inverse association 
between vitamin  K1 status and all-cause mortality [13, 14]. 
The study by Shea et al. measured circulating phylloqui-
none concentrations, which has been shown to associate with 
dietary phylloquinone intake up to intakes of 200 µg/d [27], 
and found that participants with low circulating phylloqui-
none concentrations (≤ 0.5 nmol/L) had a 19% higher risk of 
mortality compared to participants with higher circulating 
phylloquinone concentrations (> 1.0 nmol/L) [fully adjusted 
HR: 1.19 (1.03, 1.38)] [14]. Similarly, Juanola-Falgarona 
et al. reported that an increase in energy-adjusted vitamin  K1 
intake during follow-up was associated with a 36% reduced 
risk of all-cause mortality in a Mediterranean population at 
Table 1  (continued)
Data expressed as median [IQR] or n (%), unless otherwise stated
BMI, body mass index; CKD, chronic kidney disease; COPD, common obstructive pulmonary disease; DKK, Danish Krone; HRT, hormone 
replacement therapy, MET, metabolic equivalent; NSAID, Nonsteroidal anti-inflammatory drug
Fig. 1  Hazard ratios from Cox proportional hazards model with 
restricted cubic spline curves describing the association between 
vitamin  K1 intake (µg/day) and all-cause mortality, cardiovascular 
disease (CVD)-related mortality and cancer-related mortality. Haz-
ard ratios are based on models adjusted for age, sex, BMI, smoking 
status, smoking pack-years, social economic status (income), physical 
activity, alcohol intake, and education (Model 1b), and are comparing 
the specific level of vitamin  K1 intake (horizontal axis) to the median 
intake for participants in the lowest intake quintile (57 µg/day)
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high CVD risk [fully adjusted HR for highest compared to 
lowest intakes: 0.64 (0.45, 0.90)] [13]. The aforementioned 
findings support those of the current study where partici-
pants in the highest quintile of vitamin  K1 intake had a 16% 
lower risk of mortality from any cause.
There are few studies to date that have examined associa-
tions between vitamin  K1 and CVD mortality. Of the studies 
available, all reported no associations between CVD mortal-
ity and both vitamin  K1 intake [11, 13] and circulating levels 
of vitamin  K1 [14]. In the present study, higher vitamin  K1 
intakes were associated with a lower risk of CVD-related 
mortality. Interestingly, we have reported previously in this 
cohort [22] that higher vitamin  K1 intakes were indepen-
dently associated with a 21% lower risk of an atheroscle-
rotic CVD-related hospitalisation [multivariable adjusted 
HR for highest compared to lowest intakes: 0.79, 95% CI 
(0.74, 0.84)].
There is weak evidence from in vitro studies for the anti-
carcinogenic activity of vitamin  K1 [9, 10]. We found that 
a moderate to high intakes of vitamin  K1 was associated 
with a lower risk of cancer-related mortality. Four prior 
epidemiological studies that examined cancer mortality and 
vitamin  K1 intake are conflicted – three found no statisti-
cally significant association [11, 15, 16], and one reported 
an inverse association in an elderly Mediterranean popu-
lation [13]. Conflicting findings between cohorts may be 
attributed to different diets, the use of different vitamin  K1 
food databases and/or differences in the inclusion of vitamin 
K-rich foods in the respective FFQs. However, in order to 
discern the relationship between vitamin K intake and can-
cer mortality, more studies are needed in additional cohorts 
with analysis of specific cancer subtypes, due to the complex 
nature of cancer.
Vegetables are the major dietary source of vitamin  K1 
and previous studies have demonstrated an inverse associa-
tion between vegetable intake and mortality from any cause 
[28–30]. This raises the query of whether higher vitamin 
 K1 intakes are simply a marker of higher vegetable intake 
Table 2  Hazard ratios all-cause and cause-specific mortality by quintiles of vitamin  K1 intake
Hazard ratios (95% Confidence Intervals) for all-cause and cause-specific mortality during 23 years of follow-up, obtained from restricted cubic 
splines based on Cox proportional hazards models. Model 1a adjusted for age and sex; Model 1b adjusted for age, sex, BMI, smoking status, 
smoking pack-years, physical activity, alcohol intake, social economic status (income), education, and prevalent disease; Model 2 adjusted for all 
covariates in Model 1b plus energy intake and intakes of fish, red meat, processed meat, wholegrains, and fruit; Model 3 adjusted for all of the 
covariates in Model 2 plus intake of vegetables
*Median; range in parentheses (all such values)
Vitamin  K1 intake quintiles
Q1 n = 11,210 Q2 n = 11,209 Q3 n = 11,210 Q4 n = 11,209 Q5 n = 11,210
Intake (mg/d)* 57 [4–73] 87 [73–100] 113 [100–127] 142 [127–161] 192 [161–800]
All-cause mortality
No. events 3754 3034 2582 2431 2282
HR (95% CI)
Model 1a Ref 0.76 (0.74, 0.79) 0.66 (0.64, 0.68) 0.61 (0.59, 0.63) 0.58 (0.56, 0.61)
Model 1b Ref 0.88 (0.85, 0.90) 0.82 (0.79, 0.85) 0.79 (0.76, 0.83) 0.78 (0.74, 0.81)
Model 2 Ref 0.86 (0.84, 0.89) 0.81 (0.78, 0.84) 0.78 (0.75, 0.82) 0.77 (0.73, 0.81)
Model 3 Ref 0.86 (0.83, 0.89) 0.81 (0.77, 0.84) 0.78 (0.74, 0.83) 0.77 (0.71, 0.83)
CVD-related mortality
No. events 1364 1157 885 839 768
HR (95% CI)
Model 1a Ref 0.76 (0.72, 0.81) 0.65 (0.61, 0.69) 0.58 (0.54, 0.62) 0.54 (0.50, 0.59)
Model 1b Ref 0.88 (0.84, 0.94) 0.81 (0.76, 0.87) 0.77 (0.71, 0.83) 0.74 (0.68, 0.81)
Model 2 Ref 0.86 (0.81, 0.92) 0.79 (0.74, 0.85) 0.75 (0.68, 0.82) 0.72 (0.64, 0.80)
Model 3 Ref 0.87 (0.82, 0.93) 0.81 (0.74, 0.88) 0.77 (0.69, 0.87) 0.75 (0.65, 0.88)
Cancer-related mortality
No. events 1644 1325 1176 1170 1027
HR (95% CI)
Model 1a Ref 0.78 (0.74, 0.81) 0.69 (0.66, 0.73) 0.66 (0.62, 0.70) 0.63 (0.59, 0.67)
Model 1b Ref 0.88 (0.84, 0.92) 0.84 (0.79, 0.88) 0.83 (0.78, 0.88) 0.82 (0.77, 0.88)
Model 2 Ref 0.86 (0.82, 0.91) 0.82 (0.78, 0.87) 0.82 (0.76, 0.88) 0.81 (0.74, 0.88)
Model 3 Ref 0.87 (0.82, 0.91) 0.82 (0.77, 0.88) 0.82 (0.75, 0.90) 0.81 (0.72, 0.92)
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and higher diet quality, and whether components other than 
vitamin  K1 are responsible for the observed associations 
[13]. Although disentangling dietary components in obser-
vational studies is not possible, in the present study associa-
tions between vitamin  K1 intakes and all-cause mortality 
remained after adjustments were made for potential dietary 
confounders, including total vegetable intake, as well as 
within participants in the highest vegetable intake tertile. 
This suggests vitamin  K1 may provide additional benefits, 
beyond other components of a vegetable-rich diet.
In the present study, associations between total vitamin 
 K1 intakes and CVD-mortality were present in all subpopu-
lations investigated, although the number of participants 
with diabetes at baseline was low (n = 1,182), which explains 
the larger confidence intervals observed for this group. Inter-
estingly, the association between vitamin  K1 intake and can-
cer-mortality was only present in current/former smokers. 
We report that the difference in the 20-year estimated abso-
lute risk of mortality was greatest for subgroups at the high-
est risk of CVD-mortality (current smokers and those with 
diabetes) and cancer-mortality (current smokers). Thus, if 
the association between higher vitamin  K1 intakes and mor-
tality is truly causal, ensuring adequate intakes of vitamin 
 K1-rich foods in smokers and persons with diabetes could 
reduce mortality and disease burden on a population level. 
However, our data does not suggest the negative impact of 
smoking on health is negated by higher vitamin K intake, as 
smokers with higher vitamin  K1 intakes remain at a much 
higher risk of both CVD- and cancer-related mortality than 
non-smokers at any level of vitamin  K1 intake.
There are many strengths in the present study, includ-
ing a long follow-up period of 23 years with a large adult 
Fig. 2  Hazard ratios from Cox proportional hazards model with 
restricted cubic spline curves describing the association between vita-
min  K1 intake (µg/day) cardiovascular disease (CVD)-related mortal-
ity, stratified by baseline smoking status, smoking pack-years, sex, 
baseline diabetes status, and baseline hypertension status. Hazard 
ratios are based on models adjusted for age, sex, BMI, smoking sta-
tus, social economic status (income), physical activity, alcohol intake, 
and education (Model 1b), and are comparing the specific level of 
vitamin  K1 intake (horizontal axis) to the median intake for partici-
pants in the lowest intake quintile (57 µg/day)
Fig. 3  Hazard ratios from Cox proportional hazards model with 
restricted cubic spline curves describing the association between vita-
min  K1 intake (µg/day) cancer-related mortality, stratified by base-
line smoking status. Hazard ratios are based on models adjusted for 
age, sex, BMI, smoking pack-years, social economic status (income), 
physical activity, alcohol intake, and education (Model 1b), and are 
comparing the specific level of vitamin  K1 intake (horizontal axis) 
to the median intake for participants in the lowest intake quintile 
(57 µg/d)
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population. Another strength is the crosslinking with Danish 
registries, which allowed for a negligible loss to follow up, 
aided capture of mortality outcomes and participant char-
acteristics gathered at baseline, and enabled censoring of 
participants who were prescribed VKA at any point during 
follow up. We also examined whether vitamin  K1 is simply 
a marker of vegetable intake. Acknowledging the limitations 
of the study is crucial for interpretation of findings; unfor-
tunately, there was only one FFQ, administered at baseline 
and in the long follow-up period dietary changes were unac-
counted for, which may have attenuated the power to detect 
an association. Additionally, this FFQ has not been validated 
for vitamin K, however previous studies have shown that 
plasma phylloquinone positively associates with phylloqui-
none intakes up to 200 µg/day, after which the association 
plateaued, likely attributable to over-reporting of vegetable 
intakes [27]. This may explain, at least in part, the plateau 
observed in the present study but, as intake estimates were 
derived from an FFQ, caution should be taken not to extrap-
olate absolute intakes. Secondly, due the lack of comprehen-
sive vitamin  K2 nutrient databases, we did not investigate 
associations with intakes of vitamin  K2. Thirdly, the Danish 
population the cohort was drawn from is more ethnically 
and racially homogeneous than most countries, which may 
limit the generalisability of the findings. Fourthly, the cod-
ing of CVD-related and cancer-related deaths by the Danish 
Register of Causes of Death has not been validated and may 
be susceptible to misclassification bias. Most importantly, 
due to the observational nature of this work, causality can-
not be inferred.
In this prospective cohort study, dietary vitamin  K1 intake 
was inversely related to CVD-related mortality, cancer-
related mortality, and mortality from any cause. Ensuring 
adequate intakes of vitamin  K1, commonly found in foods 
such as green leafy and cruciferous vegetables, especially in 
high-risk individuals, may help to reduce CVD-related and 
cancer-related mortality at the population level.
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